Fonte: Program and Abstracts. Nome do evento: Annual Meeting of the Endocrine Society. Unidade: FM
Assunto: ENDOCRINOLOGIA
ABNT
SANTOS, R F et al. Metformin treatment changes insulin receptor bindig and tyrosine kinase activity of obese subjects with normal glucose tolerance. 1995, Anais.. Rockville: Endocrine Society, 1995. . Acesso em: 12 jul. 2024.APA
Santos, R. F., Nomizo, R., Rosco, A., & Wajchenberg, B. L. (1995). Metformin treatment changes insulin receptor bindig and tyrosine kinase activity of obese subjects with normal glucose tolerance. In Program and Abstracts. Rockville: Endocrine Society.NLM
Santos RF, Nomizo R, Rosco A, Wajchenberg BL. Metformin treatment changes insulin receptor bindig and tyrosine kinase activity of obese subjects with normal glucose tolerance. Program and Abstracts. 1995 ;[citado 2024 jul. 12 ]Vancouver
Santos RF, Nomizo R, Rosco A, Wajchenberg BL. Metformin treatment changes insulin receptor bindig and tyrosine kinase activity of obese subjects with normal glucose tolerance. Program and Abstracts. 1995 ;[citado 2024 jul. 12 ]